Effect of Buparlisib, a pan-class I PI3K inhibitor, in refractory follicular and poorly differentiated thyroid cancer
Borson-Chazot, Francoise, Dantony, Emmanuelle, Illouz, Frédéric, Lopez, Jonathan, Niccoli, Patricia, Wassermann, Johanna, Do Cao, Christine, Leboulleux, Sophie, Klein, Marc, Tabarin, Antoine, Eberlé,Journal:
Thyroid
DOI:
10.1089/thy.2017.0663
Date:
August, 2018
File:
PDF, 818 KB
2018